Thromboelastography: a review for radiologists and implications on periprocedural bleeding risk

被引:0
作者
Joseph Willis
Caleb Carroll
Virginia Planz
Samuel J. Galgano
机构
[1] University of Alabama at Birmingham School of Medicine,Department of Radiology
[2] Vanderbilt University Medical Center,Department of Radiology
[3] University of Alabama at Birmingham,undefined
来源
Abdominal Radiology | 2022年 / 47卷
关键词
Thromboelastography; Hemorrhage; Biopsy; Interventional radiology;
D O I
暂无
中图分类号
学科分类号
摘要
Thromboelastography (TEG) and rotational thromboelastometry are emerging technologies that are gaining increasing acceptance in the medical field to evaluate the coagulation status of patients on an individual level by assessing dynamic clot formation. TEG has been proven to reduce blood product use as well as improve patient outcomes in a variety of medical settings, including trauma and surgery due to the expediated nature of the test as well as the ability to determine specific deficiencies present in whole blood that are otherwise undetectable with traditional coagulation studies. Currently, no guidelines or recommendations are in place for the utilization of TEG in interventional or diagnostic radiology although access to TEG has become increasingly common in recent years. This manuscript presents a review of prior literature on the technical aspects of TEG as well as its use in various fields and explains the normal TEG-tracing parameters. Common hemodynamic abnormalities and their effect on the TEG tracing are illustrated, and the appropriate treatments for each abnormality are briefly mentioned. TEG has the potential to be a useful tool for determining the hemodynamic state of patients in both interventional and diagnostic radiology, and further research is needed to determine the value of these tests in the periprocedural setting.
引用
收藏
页码:2697 / 2703
页数:6
相关论文
共 167 条
[31]  
Fleming K(2015)Detection of elevated INR by thromboelastometry and thromboelastography in warfarin treated patients and healthy controls Thromb Res. 135 1007-undefined
[32]  
Redfern RE(2016)Targeted Thromboelastographic (TEG) Blood Component and Pharmacologic Hemostatic Therapy in Traumatic and Acquired Coagulopathy Curr Drug Targets. 17 954-undefined
[33]  
March RL(2021)Correcting Coagulopathy With Fresh Frozen Plasma in the Surgical Intensive Care Unit: How Much Do We Need to Transfuse? Am Surg. 2021 31348211023412-undefined
[34]  
Bobulski N(2013)Functional fibrinogen assay indicates that fibrinogen is critical in correcting abnormal clot strength following trauma Shock. 39 45-undefined
[35]  
Kuehne M(2013)Fibrinolysis greater than 3% is the critical value for initiation of antifibrinolytic therapy J Trauma Acute Care Surg. 75 961-undefined
[36]  
Chen JT(undefined)undefined undefined undefined undefined-undefined
[37]  
Lawson PJ(undefined)undefined undefined undefined undefined-undefined
[38]  
Moore HB(undefined)undefined undefined undefined undefined-undefined
[39]  
Moore EE(undefined)undefined undefined undefined undefined-undefined
[40]  
Stettler GR(undefined)undefined undefined undefined undefined-undefined